183 related articles for article (PubMed ID: 37741923)
21. Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial.
Ruttens D; Verleden SE; Vandermeulen E; Bellon H; Vanaudenaerde BM; Somers J; Schoonis A; Schaevers V; Van Raemdonck DE; Neyrinck A; Dupont LJ; Yserbyt J; Verleden GM; Vos R
Am J Transplant; 2016 Jan; 16(1):254-61. PubMed ID: 26372728
[TBL] [Abstract][Full Text] [Related]
22. Percentage of low attenuation area on computed tomography detects chronic lung allograft dysfunction, especially bronchiolitis obliterans syndrome, after bilateral lung transplantation.
Kubo Y; Sugimoto S; Shiotani T; Matsubara K; Hashimoto K; Tanaka S; Shien K; Suzawa K; Miyoshi K; Yamamoto H; Okazaki M; Toyooka S
Clin Transplant; 2023 Nov; 37(11):e15077. PubMed ID: 37461238
[TBL] [Abstract][Full Text] [Related]
23. Twelve-month effects of everolimus on renal and lung function in lung transplantation: differences in chronic lung allograft dysfunction phenotypes.
Patrucco F; Allara E; Boffini M; Rinaldi M; Costa C; Albera C; Solidoro P
Ther Adv Chronic Dis; 2021; 12():2040622321993441. PubMed ID: 33717427
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
[TBL] [Abstract][Full Text] [Related]
25. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).
Sato M; Ohmori-Matsuda K; Saito T; Matsuda Y; Hwang DM; Waddell TK; Singer LG; Keshavjee S
J Heart Lung Transplant; 2013 May; 32(5):484-91. PubMed ID: 23433813
[TBL] [Abstract][Full Text] [Related]
26. Chronic lung allograft dysfunction phenotypes and treatment.
Verleden SE; Vos R; Vanaudenaerde BM; Verleden GM
J Thorac Dis; 2017 Aug; 9(8):2650-2659. PubMed ID: 28932572
[TBL] [Abstract][Full Text] [Related]
27. Characterization of chronic lung allograft dysfunction phenotypes using spectral and intrabreath oscillometry.
Fu A; Vasileva A; Hanafi N; Belousova N; Wu J; Rajyam SS; Ryan CM; Hantos Z; Chow CW
Front Physiol; 2022; 13():980942. PubMed ID: 36277208
[No Abstract] [Full Text] [Related]
28. Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single-center study.
Verleden SE; Von Der Thüsen J; Van Herck A; Weynand B; Verbeken E; Verschakelen J; Dubbeldam A; Vanaudenaerde BM; Vos R; Verleden GM;
Clin Transplant; 2020 Feb; 34(2):e13781. PubMed ID: 31958356
[TBL] [Abstract][Full Text] [Related]
29. Machine Learning Algorithms Utilizing Quantitative CT Features May Predict Eventual Onset of Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Barbosa EJM; Lanclus M; Vos W; Van Holsbeke C; De Backer W; De Backer J; Lee J
Acad Radiol; 2018 Sep; 25(9):1201-1212. PubMed ID: 29472146
[TBL] [Abstract][Full Text] [Related]
30. Montelukast in chronic lung allograft dysfunction after lung transplantation.
Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
[TBL] [Abstract][Full Text] [Related]
31. Restrictive Allograft Syndrome After COVID-19 Pneumonia: A Case Report.
Ohizumi Y; Kurokawa R; Amemiya S; Ito T; Sato M; Abe O
Cureus; 2024 Feb; 16(2):e54583. PubMed ID: 38384867
[TBL] [Abstract][Full Text] [Related]
32. Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation.
Sato M; Hwang DM; Ohmori-Matsuda K; Chaparro C; Waddell TK; Singer LG; Hutcheon MA; Keshavjee S
J Heart Lung Transplant; 2012 Apr; 31(4):354-63. PubMed ID: 22330935
[TBL] [Abstract][Full Text] [Related]
33. COMP: A Potential Early Biomarker of RAS After Lung Transplantation.
Novo M; Westin J; Andersson LM; Jonsson Berdenius A; Nordén R; Magnusson JM
Transplant Direct; 2021 Aug; 7(8):e730. PubMed ID: 34291152
[TBL] [Abstract][Full Text] [Related]
34. A spirometric journey following lung transplantation.
Fuller J; Paraskeva M; Thompson B; Snell G; Westall G
Respirol Case Rep; 2014 Sep; 2(3):120-2. PubMed ID: 25473588
[TBL] [Abstract][Full Text] [Related]
35. The role of biomechanical anatomical modeling via computed tomography for identification of restrictive allograft syndrome.
Horie M; Saito T; Moseley J; D'Errico L; Salazar P; Nakajima D; Brock K; Yasufuku K; Binnie M; Keshavjee S; Paul N
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28658530
[TBL] [Abstract][Full Text] [Related]
36. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
[TBL] [Abstract][Full Text] [Related]
37. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
[TBL] [Abstract][Full Text] [Related]
38. Late-Onset Exudative Pleural Effusions Without Concomitant Airway Obstruction or Lung Parenchymal Abnormalities: A Novel Presentation of Chronic Lung Allograft Dysfunction.
Sindu D; Bansal S; Buddhdev B; McAnally K; Mohamed H; Walia R; Mohanakumar T; Tokman S
Transpl Int; 2024; 37():12395. PubMed ID: 38357217
[TBL] [Abstract][Full Text] [Related]
39. Phenotyping CLAD after single lung transplant: Limits and prognostic assessment of the 2019 ISHLT classification system.
Berra G; Huszti E; Levy L; Kawashima M; Fuchs E; Renaud-Picard B; Riddell P; Dias O; Rajagopala S; Ulahannan A; Ghany R; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2022 May; 41(5):599-607. PubMed ID: 35351385
[TBL] [Abstract][Full Text] [Related]
40. Chronic lung allograft dysfunction subtype analysis by computed tomography volumetry.
Peräkylä LH; Raivio PM; Kesävuori RI; Piilonen AK; Stark CK; Halme MK; Nykänen AI
Clin Transplant; 2022 Jan; 36(1):e14507. PubMed ID: 34634164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
